Profile
Smital Shah is Chief Financial & Business Officer at Lyell Immunopharma, Inc. since 2026.
Former roles include Independent Director at Graphite Bio, Inc., Independent Director at Pliant Therapeutics, Inc. from 2019 to 2025, Treasurer at Gilead Sciences, Inc. from 2012 to 2014, and Chief Financial & Business Officer at ProQR Therapeutics NV from 2018 to 2022.
Education includes graduate studies at Virginia Polytechnic Institute & State University, undergraduate studies at the University of Mumbai, and an MBA from Haas School of Business.
Smital Shah active positions
| Companies | Position | Start |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Director of Finance/CFO | 2026-03-08 |
Former positions of Smital Shah
| Companies | Position | End |
|---|---|---|
| PLIANT THERAPEUTICS, INC. | Director/Board Member | 2025-06-04 |
| PROQR THERAPEUTICS N.V. | Director of Finance/CFO | 2022-09-30 |
| GILEAD SCIENCES, INC. | Treasurer | 2014-08-31 |
| LENZ THERAPEUTICS, INC. | Director/Board Member | - |
Training of Smital Shah
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Virginia Polytechnic Institute & State University
Virginia Polytechnic Institute & State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Haas School of Business
Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProQR Therapeutics NV
ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company focuses on discovering and developing novel therapies for the treatment of fibrosis | Health Technology |
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
Graphite Bio, Inc.
Graphite Bio, Inc. BiotechnologyHealth Technology Operates as gene editing company for DNA integrations | Health Technology |
- Stock Market
- Insiders
- Smital Shah
















